Conatus Pharmaceuticals (CNAT) in Focus: Stock Surges 14.3%
Conatus Pharmaceuticals Inc. (CNAT) was a big mover last session, as the company saw its shares surge over 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 39% in the past one-month time frame.
None of the estimates for this medical products stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Conatus Pharmaceuticals currently carries a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.
A better-ranked stock in the same industry is ICU Medical, Inc. (ICUI), sporting a Zacks Rank #1 (Strong Buy).
Is CNAT going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
CONATUS PHARMA (CNAT): Free Stock Analysis Report
ICU MEDICAL INC (ICUI): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
